Source CBS News · Published · Open the original ↗
Capability
Doctor reacts to AI breast cancer tool
The providers of Clairity Breast, a new FDA-approved AI tool, claim their tech provides an accurate five-year risk assessment for breast cancer, for just $249. Dr. Céline Gounder shares her thoughts.
CBS News publishes this report on its own site. Supence shows only what the publisher allows to be quoted.